Clinical Trial

Key Diagnostic & Therapeutic Technologies for Severe Acute High Altitude Disease (SAHAD): Integration and Application

Study acronym: SAHAD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to establish a key technical system for the diagnosis and treatment of severe acute mountain sickness based on real-world clinical data in Xizang, develop standardized diagnosis and treatment protocols and an intelligent early warning model, validate its efficacy through multicenter studies, and innovate diagnostic and therapeutic technologies. It will achieve early identification, precise diagnosis, standardized treatment, and intelligent warning of severe acute mountain sickness, comprehensively improving its prevention, control and treatment success rate.
Trial Details
NCT Number NCT07639931
Lead Sponsor Tibet Autonomous Region People's Hospital
Conditions Severe High Altitude Pulmonary Edema, Severe High Altitude Cerebral Edema
Enrollment 3,035 participants
Start Date 2026-07-01
Primary Completion 2028-12-20 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-10